Free Trial

20 High-Yield Dividend Stocks that Could Ruin Your Retirement - 4 of 20

→ Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad)
Slide 4
Back to 3
Continue to 5
 
Back to 3
Continue to 5
 

Gilead Sciences (NASDAQ:GILD)

Dividend Yield
4.58%
Annual Dividend Payout
$3.08
Earnings Per Share
$0.36
Payout Ratio
855.6%
Consensus Rating
Hold
Consensus Price Target
$83.69 (25.1% Upside)

About Gilead Sciences

Gilead Sciences logoGilead Sciences, Inc, a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. Read More 
 
Insider Trades by Quarter for Gilead Sciences (NASDAQ:GILD)

Slide 4
Back to 3
Continue to 5
 

Dividend-like income from non-dividend stocks (Ad)

This coming Wednesday @ 7 PM EST you're going to discover… How to find safe value in the stocks you already own with simple Cash Flow Trade Strategies.

Click here to register for free.

More From MarketBeat
Dividend-like income from non-dividend stocks
from Unstoppable Prosperity
7 Stocks Under $20 You Won’t Want to Miss
from MarketBeat
Top 5 Tech Stocks to Buy for 2024
from Daily Market Alerts
7 Manufacturing Stocks to Buy as Sector Activity Increases
from MarketBeat
The most important AI company you've never heard of
from Manward Press
10 Rock-Solid Dividend Paying Stocks to Add to Your Portfolio
from MarketBeat